Melitracen
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292007This classification denotes an anthracene and tricyclic antidepressive agent with the molecular formula C21H25N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q7T0Y1109Z, chemically known as 3-(10,10-dimethyl-9(10h)-anthracenylidene)-n,n-dimethyl-1-propanamine but generally known as melitracen, which bears US NIH Compound Identifier 25382. European Medicines Agency schedules Melitracen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08725MIG. World Health Organization schedules melitracen in its Anatomical Therapeutic Chemical (ATC) Classification. MELITRACEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule melitracen under HS 29214980 and SITC 51454. As of Q4 2014, MELITRACEN remains the US FDA Preferred Term for this commodity. SMILES: N(CC/C=C1/c2c(C(c3c1cccc3)(C)C)cccc2)(C)C.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.